Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
Expressing support for the designation of September 30, 2025, as Rare Cancer Day to highlight the ch
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
Expressing support for the designation of September 30, 2025, as Rare Cancer Day to highlight the ch
Key Policy Areas
Government
Primary Purpose
Expressing support for the designation of September 30, 2025, as Rare Cancer Day to highlight the ch
Policy Domains
Legislative Strategy
"Policy"
Sponsors
Legislative Progress
In CommitteeMr. Kelly of Pennsylvania (for himself, Ms. Wasserman Schultz, Mr. …
Referred to the House Committee on Energy and Commerce.
Submitted in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Medical research institutions, Pharmaceutical companies
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology